Clinical Trial: Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis

Brief Summary: The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.

Detailed Summary:
Sponsor: Medicis Global Service Corporation

Current Primary Outcome: Symptom Improvement (investigator assessment) [ Time Frame: Week 4 ]

Proportion of subjects with a response of clear or almost clear, and at least a two-grade improvement from baseline to week 4


Original Primary Outcome: Same as current

Current Secondary Outcome: Symptom Improvement (subject assessment) [ Time Frame: Weeks 2 and 4 ]

Assess the change in the pruritus score from baseline to week 2 and to week 4.


Original Secondary Outcome: Same as current

Information By: Medicis Global Service Corporation

Dates:
Date Received: October 7, 2012
Date Started: September 2012
Date Completion:
Last Updated: January 7, 2013
Last Verified: January 2013